Annual Report

Overview

The report records 2014 consolidated net sales of ¥333,446 million and highlights the launches of G-Lasta® and Dovobet®. It describes ProStrakan's acquisition of Archimedes Pharma and continued global development alliances for KW-0761. Environmental disclosures report 354,000 tons of Group CO2 emissions and a fiscal 2020 target to keep emissions no more than 85% of the fiscal 1990 level. The report also discusses reforms following inappropriate participation in clinical research and Group-wide antibribery measures.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2014
Period: 1 January 2014 – 31 December 2014
Language: English
Pages
File size
Restatement: Disclosed

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services